What Can We Learn About Pancreatic Adenocarcinoma from Imaging?

PDAC is an aggressive and morbid disease that requires detailed assessments and timely interventions from the imaging members of a multidisciplinary care team. Although CT is the primary modality for detection, staging, and surveillance of PDAC, ERCP, and EUS serve an equally important role in diagnosis and in management of complications. The interpretation of these imaging studies to determine PDAC resectability and treatment pathways should be made as part of a multidisciplinary care discussion involving radiologists, gastroenterologists, surgeons, oncolo-gists, and radiation oncologists.